Table 2.
Splitting criteria | Cohort | Subset | Cancer | Noncancer | Total | Chi-square |
---|---|---|---|---|---|---|
Split by 6 and 16 | C1 | 14 | 43 | 57 | 76.172 | |
and | 54 | 126 | 180 | |||
17 | 7 | 24 | ||||
C2 | 23 | 21 | 44 | 87.265 | ||
and | 43 | 123 | 166 | |||
19 | 8 | 27 | ||||
Split by 6 | C1 | 14 | 43 | 57 | 155.37 | |
71 | 133 | 204 | ||||
C2 | 23 | 21 | 44 | 134.35 | ||
62 | 131 | 193 | ||||
Split by 6 and 8 | C1 | 14 | 43 | 57 | 35.92 | |
and mm | 7 | 65 | 72 | |||
64 | 68 | 132 | ||||
C2 | 23 | 21 | 44 | 27.51 | ||
and | 19 | 64 | 83 | |||
43 | 67 | 110 |
Note: Chi-square analysis: For split by 6 and 16 mm and 6 and 8 mm, and , critical value is 5.991; for split by 6 mm only and , critical value is 3.84. Here none of them are significant.